Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - APPLIED DNA SCIENCES INC | tm2037742d1_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - APPLIED DNA SCIENCES INC | tm2037742d1_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - APPLIED DNA SCIENCES INC | tm2037742d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - APPLIED DNA SCIENCES INC | tm2037742d1_ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - APPLIED DNA SCIENCES INC | tm2037742d1_ex21-1.htm |
| EX-10.47 - EXHIBIT 10.47 - APPLIED DNA SCIENCES INC | tm2037742d1_ex10-47.htm |
| EX-10.46 - EXHIBIT 10.46 - APPLIED DNA SCIENCES INC | tm2037742d1_ex10-46.htm |
| EX-4.1 - EXHIBIT 4.1 - APPLIED DNA SCIENCES INC | tm2037742d1_ex4-1.htm |
| 10-K - FORM 10-K - APPLIED DNA SCIENCES INC | tm2037742d1_10k.htm |
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the incorporation by reference in the Registration Statement of Applied DNA Sciences, Inc. on Form S-1 (File Nos. 333-233830 and 333-234664), Form S-3 (File Nos. 333-202432, 333-220481, 333-218158, 333-214920, 333-208162 and 333-238557) and S-8 (File Nos. 333-182350, 333-205123, 333-231944 and 333-249365), of our report dated December 17, 2020 which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the consolidated financial statements of Applied DNA Sciences, Inc. as of September 30, 2020 and 2019, and for each of the two years in the period ended September 30, 2020, which report is included in this Annual Report on Form 10-K of Applied DNA Sciences, Inc. for the year ended September 30, 2020.
| /s/Marcum llp | |
| Marcum llp | |
| Melville, NY | |
| December 17, 2020 |